Companies: 10,795·Total market cap: $144.5T
OncoVista Innovative Therapies, Inc.

OncoVista Innovative Therapies, Inc.

OVITOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$2356
P/E Ratio—
52W High$0.0004
52W Low$0.0001
Shares OutstandingFinancialsRevenue

OncoVista Innovative Therapies, Inc. (OVIT) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

OVIT · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
21.7M▲ +0.11% YoY Change
FY · as of Dec 31, 2014 · Reported in USD
vs 21.6M in FY 2013
Diluted Shares Outstanding
21.7M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+0.11%
year-over-year
Float (Free Float)
23.6M
publicly tradable shares
100.0% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+0.5%
2011 → 2014
5-Year CAGRincreasing
+3.3%
2009 → 2014
10-Year CAGRincreasing
+2.6%
2004 → 2014
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2014Latest
Diluted Shares: 21.7M
21.7M
+0.11%
FY 2013
Diluted Shares: 21.6M
21.6M
+0.54%
FY 2012
Diluted Shares: 21.5M
21.5M
+0.95%
FY 2011
Diluted Shares: 21.3M
21.3M
+4.04%
FY 2010
Diluted Shares: 20.5M
20.5M
+11.17%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs OVIT
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
OncoVista Innovative Therapies, Inc.OVIT
OncoVista Innovative Therapies, Inc.YOU
21.7M—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

OncoVista Innovative Therapies, Inc. (OVIT) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2014, OncoVista Innovative Therapies, Inc. reports 21.7M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

OncoVista Innovative Therapies, Inc.'s basic shares outstanding (21.7M) represents currently issued shares. Diluted shares outstanding (21.7M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

OncoVista Innovative Therapies, Inc.'s float is 23.6M (100.0% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float23.6M(100.0%)
Outstanding23.6M

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

OncoVista Innovative Therapies, Inc. (OVIT) shares outstanding history from 2004 to 2014. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

OncoVista Innovative Therapies, Inc. shares outstanding for the fiscal year ending December 31, 2014 were 21.7M, a 0.11% increase year-over-year. OncoVista Innovative Therapies, Inc. FY 2014 shares outstanding were 21.7M, a +0.11% increase from FY 2013.

OncoVista Innovative Therapies, Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +2.6% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

OVIT shares outstanding · 4 questions

As of December 31, 2014, OncoVista Innovative Therapies, Inc. (OVIT) has approximately 21.7M basic shares outstanding and 21.7M diluted shares outstanding. This represents a +0.11% year-over-year increase from FY 2013 (21.6M). The increase may reflect equity compensation issuances or secondary offerings.

OVIT shares outstandinghow many shares does OVIT haveOVIT basic shares 2014OVIT diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · OncoVista Innovative Therapies, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09